Corcept Therapeutics (CORT) News Today $52.98 -2.16 (-3.92%) (As of 03:28 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period World Investment Advisors LLC Invests $503,000 in Corcept Therapeutics Incorporated (NASDAQ:CORT)World Investment Advisors LLC purchased a new position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 10,876 shares of the biotechnology company's stock, vaDecember 18 at 4:44 AM | marketbeat.comCorcept Therapeutics presents results from relacorilant studyDecember 17 at 10:10 AM | markets.businessinsider.comCorcept Therapeutics Incorporated (NASDAQ:CORT) Short Interest Down 7.0% in NovemberCorcept Therapeutics Incorporated (NASDAQ:CORT - Get Free Report) was the target of a significant decrease in short interest in the month of November. As of November 30th, there was short interest totalling 17,050,000 shares, a decrease of 7.0% from the November 15th total of 18,340,000 shares. Approximately 18.9% of the company's shares are sold short. Based on an average daily volume of 999,000 shares, the short-interest ratio is currently 17.1 days.December 16 at 7:37 PM | marketbeat.comCorcept's Relacorilant Shows Long-Term Cardiometabolic Benefits In Hypercortisolism PatientsDecember 16 at 2:56 PM | markets.businessinsider.comCorcept’s Phase 3 Long-Term Extension Study of Relacorilant Demonstrated Durable Cardiometabolic Improvements in Patients with HypercortisolismDecember 16 at 9:54 AM | finance.yahoo.comStifel Financial Corp Buys 20,546 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)Stifel Financial Corp increased its position in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 30.0% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 88,967 shares of the biotechnology company's stock after aDecember 16 at 3:40 AM | marketbeat.comState Street Corp Acquires 19,893 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)State Street Corp boosted its holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 0.6% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,519,263 shares of the biotechnology company's stock after purchDecember 14, 2024 | marketbeat.comCorcept Therapeutics' FDA-Approved Korlym Hits Main Goal In Cushing's Syndrome Patients With Difficult-To-Control DiabetesDecember 13, 2024 | benzinga.comInsider Selling: Corcept Therapeutics Incorporated (NASDAQ:CORT) Director Sells 2,200 Shares of StockDecember 13, 2024 | insidertrades.comVerition Fund Management LLC Lowers Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)Verition Fund Management LLC trimmed its position in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 76.8% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 8,758 shares of the biotechnology company's stock afterDecember 13, 2024 | marketbeat.comCorcept Therapeutics Diabetes Drug Korlym Meets Primary Endpoint in StudyDecember 12, 2024 | marketwatch.comOptimistic Outlook for Corcept Therapeutics Amid Promising Developments and Regulatory AdvantagesDecember 12, 2024 | markets.businessinsider.comCorcept Therapeutics Inc (CORT) Announces Positive Results from CATALYST StudyDecember 12, 2024 | gurufocus.comCorcept Therapeutics says CATALYST trial met primary endpointDecember 12, 2024 | tipranks.comCorcept Announces Positive Results in Treatment Phase of CATALYST Trial in Patients With Hypercortisolism (Cushing's Syndrome) and Difficult-to-Control DiabetesDecember 12, 2024 | businesswire.comCorcept Therapeutics Incorporated (NASDAQ:CORT) Receives Consensus Rating of "Buy" from AnalystsDecember 12, 2024 | americanbankingnews.comCorcept Therapeutics Fall 3.5 After ALS Drug Fails TrialDecember 11, 2024 | marketwatch.comCorcept says DAZALS study did not meet primary endpointDecember 11, 2024 | markets.businessinsider.comCorcept Therapeutics Inc (CORT) Announces DAZALS Study Results for ALS TreatmentDecember 11, 2024 | gurufocus.comCorcept Therapeutics' ALS drug fails in mid-stage trialDecember 11, 2024 | reuters.comCorcept Therapeutics Incorporated Common Stock (CORT)December 11, 2024 | nasdaq.comCorcept Announces Results From Phase 2 Study of Dazucorilant in Patients With Amyotrophic Lateral Sclerosis (ALS)December 11, 2024 | businesswire.comExecutive Wealth Management LLC Takes Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)Executive Wealth Management LLC acquired a new stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 60,594 shares of the biotechnology company'sDecember 10, 2024 | marketbeat.comTanaka Capital Management Inc. Has $5.19 Million Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)Tanaka Capital Management Inc. increased its stake in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 11.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 112,136 shares of the biotechnology company's stockDecember 9, 2024 | marketbeat.comCorcept Therapeutics Incorporated (NASDAQ:CORT) Shares Sold by Two Sigma Advisers LPTwo Sigma Advisers LP decreased its stake in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 11.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 457,100 shares of the biotechnology companDecember 9, 2024 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 18,179 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC decreased its position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 8.2% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. ThDecember 9, 2024 | marketbeat.comJanus Henderson Group PLC Sells 17,793 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)Janus Henderson Group PLC trimmed its position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 5.2% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 324,017 shares of the biotechnology company'sDecember 8, 2024 | marketbeat.comPositive Outlook for Corcept Therapeutics Amid Phase III Delays and Market Opportunities for RelacorilantDecember 7, 2024 | markets.businessinsider.comPiper Sandler Sticks to Their Buy Rating for Corcept Therapeutics (CORT)December 7, 2024 | markets.businessinsider.comFmr LLC Has $63.12 Million Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)Fmr LLC increased its stake in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 24.6% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,363,922 shares of the biotechnology company's stDecember 7, 2024 | marketbeat.comCorcept Therapeutics (NASDAQ:CORT) shareholders have earned a 34% CAGR over the last five yearsDecember 4, 2024 | finance.yahoo.comJacobs Levy Equity Management Inc. Boosts Stock Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)Jacobs Levy Equity Management Inc. raised its stake in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 40.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,223,781 shares of the biotechnology company's stockDecember 4, 2024 | marketbeat.comCaptrust Financial Advisors Has $4.80 Million Stake in Corcept Therapeutics Incorporated (NASDAQ:CORT)Captrust Financial Advisors lowered its stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 15.7% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 103,740 shareDecember 4, 2024 | marketbeat.comBNP Paribas Financial Markets Has $4.63 Million Stock Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)BNP Paribas Financial Markets cut its stake in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 46.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 100,088 shares of the biotechDecember 4, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Acquires 53,191 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)Charles Schwab Investment Management Inc. lifted its stake in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 5.5% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,026,487 shares of tDecember 2, 2024 | marketbeat.comAlgert Global LLC Increases Stake in Corcept Therapeutics Incorporated (NASDAQ:CORT)Algert Global LLC grew its position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 216.2% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 40,115 shares of the biotechnology company's stock after buying an additNovember 28, 2024 | marketbeat.comCorcept Therapeutics: A Most Promising And Compelling BiotechNovember 27, 2024 | seekingalpha.comJoseph Douglas Lyon Sells 1,411 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) StockNovember 27, 2024 | insidertrades.comAlpha DNA Investment Management LLC Invests $464,000 in Corcept Therapeutics Incorporated (NASDAQ:CORT)Alpha DNA Investment Management LLC purchased a new stake in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 10,016 shares of the biotechnologyNovember 25, 2024 | marketbeat.comCerity Partners LLC Trims Stake in Corcept Therapeutics Incorporated (NASDAQ:CORT)Cerity Partners LLC trimmed its position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 9.4% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 611,784 shares of the biotechnology company's stockNovember 25, 2024 | marketbeat.comVictory Capital Management Inc. Grows Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)Victory Capital Management Inc. grew its holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 49.2% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 41,823 shares of the biotechnology comNovember 25, 2024 | marketbeat.comFY2024 Earnings Estimate for CORT Issued By Zacks ResearchCorcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) - Stock analysts at Zacks Research upped their FY2024 EPS estimates for Corcept Therapeutics in a research note issued on Wednesday, November 20th. Zacks Research analyst K. Das now forecasts that the biotechnology company will post eaNovember 25, 2024 | marketbeat.comCorcept Shares Rise More Than 60% in Three Months: Here's WhyNovember 22, 2024 | msn.comZacks Research Issues Positive Estimate for CORT EarningsCorcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) - Zacks Research increased their Q4 2024 earnings estimates for shares of Corcept Therapeutics in a note issued to investors on Wednesday, November 20th. Zacks Research analyst K. Das now anticipates that the biotechnology company willNovember 22, 2024 | marketbeat.comEmpowered Funds LLC Makes New Investment in Corcept Therapeutics Incorporated (NASDAQ:CORT)Empowered Funds LLC acquired a new stake in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 38,541 shares of the biotechnologyNovember 21, 2024 | marketbeat.comCorcept Therapeutics Incorporated (NASDAQ:CORT) Shares Acquired by Connor Clark & Lunn Investment Management Ltd.Connor Clark & Lunn Investment Management Ltd. increased its holdings in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 20.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 859,563 shares of the bNovember 20, 2024 | marketbeat.comCornercap Investment Counsel Inc. Has $426,000 Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)Cornercap Investment Counsel Inc. cut its position in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 59.9% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 9,212 shares of the biotechnology company's stock after selling 13November 17, 2024 | marketbeat.comRoyce & Associates LP Has $16.81 Million Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)Royce & Associates LP lifted its position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 3.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 363,272 shares of the biotechnolNovember 16, 2024 | marketbeat.comIntellectus Partners LLC Purchases Shares of 54,859 Corcept Therapeutics Incorporated (NASDAQ:CORT)Intellectus Partners LLC acquired a new position in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 54,859 shares of the biotechnology company'sNovember 15, 2024 | marketbeat.comCorcept Therapeutics Incorporated (NASDAQ:CORT) Shares Sold by Principal Financial Group Inc.Principal Financial Group Inc. lessened its holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 4.0% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 495,658 shares of the biotechnology companyNovember 14, 2024 | marketbeat.com Get Corcept Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CORT and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now CORT Media Mentions By Week CORT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CORT News Sentiment▼0.540.55▲Average Medical News Sentiment CORT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CORT Articles This Week▼247▲CORT Articles Average Week Get Corcept Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CORT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Royalty Pharma News Today Jazz Pharmaceuticals News Today Perrigo News Today Supernus Pharmaceuticals News Today Pacira BioSciences News Today Omeros News Today Nektar Therapeutics News Today Assembly Biosciences News Today Cumberland Pharmaceuticals News Today Eli Lilly and Company News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CORT) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredAI Crypto Tool Could Send One Coin SOARING…The #1 AI Coin to Buy Rapid growth predicted for little-known AI crypto projectCrypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corcept Therapeutics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Corcept Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CORT Stock Alerts